Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: Impact of dose regimen, passage, cryopreservation, and antibiotic therapy

S. Horie; C. Masterson; Jack Brady; P. Loftus; Emma Horan; Lisa O'Flynn; S. Elliman; F. Barry; T. O'Brien; J.G. Laffey; D. O'Toole

doi:10.1186/s13287-020-01624-8

Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: Impact of dose regimen, passage, cryopreservation, and antibiotic therapy

S. Horie
, C. Masterson
, Jack Brady
, P. Loftus
, Emma Horan
, Lisa O'Flynn
, S. Elliman
, F. Barry
, T. O'Brien
, J.G. Laffey
, D. O'Toole

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

32 Citations (Scopus)

Original language	Undefined/Unknown
Journal	Stem Cell Research and Therapy
DOIs	https://doi.org/10.1186/s13287-020-01624-8
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13287-020-01624-8

Cite this

Horie, S., Masterson, C., Brady, J., Loftus, P., Horan, E., O'Flynn, L., Elliman, S., Barry, F., O'Brien, T., Laffey, J. G., & O'Toole, D. (2020). Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: Impact of dose regimen, passage, cryopreservation, and antibiotic therapy. Stem Cell Research and Therapy. https://doi.org/10.1186/s13287-020-01624-8

@article{8c207b2afcc043e4932b34028b6aa74f,

title = "Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: Impact of dose regimen, passage, cryopreservation, and antibiotic therapy",

author = "S. Horie and C. Masterson and Jack Brady and P. Loftus and Emma Horan and Lisa O'Flynn and S. Elliman and F. Barry and T. O'Brien and J.G. Laffey and D. O'Toole",

year = "2020",

doi = "10.1186/s13287-020-01624-8",

language = "Undefined/Unknown",

journal = "Stem Cell Research and Therapy",

issn = "1757-6512",

publisher = "BioMed Central Ltd",

}

Horie, S, Masterson, C, Brady, J, Loftus, P, Horan, E, O'Flynn, L, Elliman, S, Barry, F , O'Brien, T , Laffey, JG & O'Toole, D 2020, 'Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: Impact of dose regimen, passage, cryopreservation, and antibiotic therapy', Stem Cell Research and Therapy. https://doi.org/10.1186/s13287-020-01624-8

TY - JOUR

T1 - Umbilical cord-derived CD362+ mesenchymal stromal cells for E. coli pneumonia: Impact of dose regimen, passage, cryopreservation, and antibiotic therapy

AU - Horie, S.

AU - Masterson, C.

AU - Brady, Jack

AU - Loftus, P.

AU - Horan, Emma

AU - O'Flynn, Lisa

AU - Elliman, S.

AU - Barry, F.

AU - O'Brien, T.

AU - Laffey, J.G.

AU - O'Toole, D.

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85081668342&partnerID=MN8TOARS

U2 - 10.1186/s13287-020-01624-8

DO - 10.1186/s13287-020-01624-8

M3 - Article

SN - 1757-6512

JO - Stem Cell Research and Therapy

JF - Stem Cell Research and Therapy

ER -

Umbilical cord-derived CD362<sup>+</sup> mesenchymal stromal cells for E. coli pneumonia: Impact of dose regimen, passage, cryopreservation, and antibiotic therapy

UN SDGs

Access to Document

Other files and links

Cite this